Cardiovascular Diseases

Use of risk chart algorithms for the identification of psoriatic arthritis patients at high risk for cardiovascular disease: findings derived from the project CARMA cohort after a 7.5-year follow-up period
Jessica Polo y La Borda, Santos Castañeda, Elena Heras-Recuero, Fernando Sánchez-Alonso, Zulema Plaza, Carmen García Gómez, Ivan Ferraz-Amaro, Jesús Tomás Sanchez-Costa, Olga Carmen Sánchez-González, Ana Isabel Turrión-Nieves, Ana Perez-Alcalá, Carolina Pérez-García, Carlos González-Juanatey, Javier Llorca, Miguel Angel Gonzalez-Gay

RMD Open Apr 2024, 10 (2) e004207; DOI: 10.1136/rmdopen-2024-004207
Risk of extended major adverse cardiovascular event endpoints with tofacitinib versus TNF inhibitors in patients with rheumatoid arthritis: a post hoc analysis of a phase 3b/4 randomised safety study
Maya H Buch, Deepak L Bhatt, Christina Charles-Schoeman, Jon T Giles, Ted Mikuls, Gary G Koch, Steven Ytterberg, Edward Nagy, Hyejin Jo, Kenneth Kwok, Carol A Connell, Karim Richard Masri, Arne Yndestad

RMD Open Apr 2024, 10 (2) e003912; DOI: 10.1136/rmdopen-2023-003912
Myocardial infarction in a population-based cohort of patients with biopsy-confirmed giant cell arteritis in southern Sweden
Pavlos Stamatis, Moman Aladdin Mohammad, Karl Gisslander, Peter A Merkel, Martin Englund, Carl Turesson, David Erlinge, Aladdin J Mohammad

RMD Open Apr 2024, 10 (2) e003960; DOI: 10.1136/rmdopen-2023-003960
Re-evaluating the mythical divide between traditional and novel cardiovascular risk factors in rheumatoid arthritis
Eirik Ikdahl, Mats Julius Stensrud

RMD Open Mar 2024, 10 (1) e003954; DOI: 10.1136/rmdopen-2023-003954
Filling gaps in female gout: a cross-sectional study of comorbidities in 192 037 hospitalised patients
Enrique Rodríguez-Sosa, Eugenio De Miguel, Fernando Borrás, Mariano Andrés

RMD Open Jun 2023, 9 (2) e003191; DOI: 10.1136/rmdopen-2023-003191
Comparative cardiovascular safety with janus kinase inhibitors and biological disease-modifying antirheumatic drugs as used in clinical practice: an observational cohort study from Sweden in patients with rheumatoid arthritis
Hannah Bower, Thomas Frisell, Daniela di Giuseppe, Benedicte Delcoigne, Johan Askling

RMD Open Nov 2023, 9 (4) e003630; DOI: 10.1136/rmdopen-2023-003630
Diffusing capacity of lungs for carbon monoxide associated with subclinical myocardial impairment in systemic sclerosis: A cardiac MR study
Huilin He, Xinyu Tong, Zihan Ning, Jiaxin Zhou, Chenlin Du, Yuhua Wang, Qian Wang, Dong Xu, Xiaofeng Zeng, Zuo-Xiang He, Xihai Zhao

RMD Open Dec 2023, 9 (4) e003391; DOI: 10.1136/rmdopen-2023-003391
Utilisation of cardiovascular preventive services in a rheumatoid arthritis population-based cohort
Daniel Montes, Cassondra A Hulshizer, Elena Myasoedova, John M Davis, Andrew C Hanson, Ali Duarte-Garcia, Gabriel Figueroa-Parra, Baptiste Chevet, Cynthia S Crowson

RMD Open Nov 2023, 9 (4) e003318; DOI: 10.1136/rmdopen-2023-003318
Sex-specific difference in cardiac function in patients with systemic sclerosis: association with cardiovascular outcomes
Tea Gegenava, Federico Fortuni, Nina Marijn van Leeuwen, Anders H Tennoe, Anna-Maria Hoffmann-Vold, Ruxandra Jurcut, Adrian Giuca, Laura Groseanu, Felix Tanner, Oliver Distler, Jeroen J Bax, Jeska De Vries-Bouwstra, Nina Ajmone Marsan

RMD Open Nov 2023, 9 (4) e003380; DOI: 10.1136/rmdopen-2023-003380
Characteristics and outcome of critically ill patients with systemic rheumatic diseases referred to the intensive care unit
Mathias Schneeweiss-Gleixner, Caroline Hillebrand, Stephanie Jaksits, Jonathan Fries, Michael Zauner, Gottfried Heinz, Gürkan Sengölge, Thomas Staudinger, Christian Zauner, Daniel Aletaha, Klaus P Machold, Peter Schellongowski, Manuel Bécède

RMD Open Nov 2023, 9 (4) e003287; DOI: 10.1136/rmdopen-2023-003287

Main menu

Cardiovascular Diseases

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Cardiovascular Diseases

Pages